More than 3.5 billion large varieties of shadow agents will be taken down.

On August 15th, the registration status of the iodized kesha alcohol injection (CYHS1700419) produced by Staly according to the imitation 4 categories was changed to "in approval" and is expected to be approved and evaluated in the near past.
2019, China's public medical institutions terminal iodized kesha alcohol sales of more than 3.5 billion yuan, Hengrui Pharmaceuticals accounted for 50.48 percent of the market share.
Iodine kesalol, developed by GE Healthcare AS (General Electric), is the only X-ray diagnostic contrast agent with blood impermeability for cardiovascular tract, cerebrovascular angiology (conventional), perennial angioencephaly (conventional), excretion urinary tract angiitis, and computer fault scanning (CT), which can cause abnormal structures or lesions to develop to distinguish healthy tissues and pathological tissues.
meters of intranet data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal iodized kesha alcohol injection sales of more than 3.5 billion yuan.
, Hengrui Pharmaceuticals has a market share of 50.48 per cent and General Electric 34.14 per cent.
is the domestic image agent raw material drug leader, the main products are iodized sea alcohol, iodized kesha alcohol, iodized parol raw materials and iodine sea alcohol hydrolyte, iodized Buddha alcohol hydrolyte and other intermediates.
by virtue of the rich advantages of raw materials and drugs, Steyri actively layout "intermediates - raw materials - preparations" of the entire industrial chain.
Steyri shadow agent preparation product listing application source: Mi net one-click search at present, Steyri has submitted to CDE iodized sea alcohol injection, iodized parol injection, iodized kesha alcohol injection, iodized Buddha alcohol injection, iodine Mepple injection and other 5 models of shadow application.
, iodized par alcohol injections, iodized sea alcohol injections have been approved and evaluated as such.
the registration status of iodized kesha alcohol injection has been changed to "in approval", if successfully approved will become the third Steyri shadow agent preparation products.
source: Minet Database, NMPA.